TickerFacts.

Grace Therapeutics, Inc. (GRCE): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2022-03-31
$76.0K2021-03-31: $76.0K2022-03-31: $0$0
2021-03-31 Cost of Revenue (USD) 2022-03-31
Period endedCost of RevenueChange YoYSource filing
2022-03-31$0-100.0%2022-06-21, From 2021-04-01
2021-03-31$76.0Kn/a2022-06-21, From 2020-04-01